Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 138

2.

The Mycobacterium tuberculosis cmaA2 gene encodes a mycolic acid trans-cyclopropane synthetase.

Glickman MS, Cahill SM, Jacobs WR Jr.

J Biol Chem. 2001 Jan 19;276(3):2228-33.

3.

Redundant function of cmaA2 and mmaA2 in Mycobacterium tuberculosis cis cyclopropanation of oxygenated mycolates.

Barkan D, Rao V, Sukenick GD, Glickman MS.

J Bacteriol. 2010 Jul;192(14):3661-8. doi: 10.1128/JB.00312-10.

4.
5.

Crystal structures of mycolic acid cyclopropane synthases from Mycobacterium tuberculosis.

Huang CC, Smith CV, Glickman MS, Jacobs WR Jr, Sacchettini JC.

J Biol Chem. 2002 Mar 29;277(13):11559-69.

6.

Thiacetazone, an antitubercular drug that inhibits cyclopropanation of cell wall mycolic acids in mycobacteria.

Alahari A, Trivelli X, Guérardel Y, Dover LG, Besra GS, Sacchettini JC, Reynolds RC, Coxon GD, Kremer L.

PLoS One. 2007 Dec 19;2(12):e1343.

8.

Temperature-dependent regulation of mycolic acid cyclopropanation in saprophytic mycobacteria: role of the Mycobacterium smegmatis 1351 gene (MSMEG_1351) in CIS-cyclopropanation of alpha-mycolates.

Alibaud L, Alahari A, Trivelli X, Ojha AK, Hatfull GF, Guerardel Y, Kremer L.

J Biol Chem. 2010 Jul 9;285(28):21698-707. doi: 10.1074/jbc.M110.125724.

9.

Investigating the function of the putative mycolic acid methyltransferase UmaA: divergence between the Mycobacterium smegmatis and Mycobacterium tuberculosis proteins.

Laval F, Haites R, Movahedzadeh F, Lemassu A, Wong CY, Stoker N, Billman-Jacobe H, Daffé M.

J Biol Chem. 2008 Jan 18;283(3):1419-27.

10.

Mycobacterium tuberculosis lacking all mycolic acid cyclopropanation is viable but highly attenuated and hyperinflammatory in mice.

Barkan D, Hedhli D, Yan HG, Huygen K, Glickman MS.

Infect Immun. 2012 Jun;80(6):1958-68. doi: 10.1128/IAI.00021-12.

11.
12.
13.

Phosphorylation of mycobacterial PcaA inhibits mycolic acid cyclopropanation: consequences for intracellular survival and for phagosome maturation block.

Corrales RM, Molle V, Leiba J, Mourey L, de Chastellier C, Kremer L.

J Biol Chem. 2012 Jul 27;287(31):26187-99. doi: 10.1074/jbc.M112.373209.

14.
15.

MMAS-1, the branch point between cis- and trans-cyclopropane-containing oxygenated mycolates in Mycobacterium tuberculosis.

Yuan Y, Crane DC, Musser JM, Sreevatsan S, Barry CE 3rd.

J Biol Chem. 1997 Apr 11;272(15):10041-9.

17.

Separation and characterization of individual mycolic acids in representative mycobacteria.

Watanabe M, Aoyagi Y, Ridell M, Minnikin DE.

Microbiology. 2001 Jul;147(Pt 7):1825-37.

PMID:
11429460
18.

Identification of a gene involved in the biosynthesis of cyclopropanated mycolic acids in Mycobacterium tuberculosis.

Yuan Y, Lee RE, Besra GS, Belisle JT, Barry CE 3rd.

Proc Natl Acad Sci U S A. 1995 Jul 3;92(14):6630-4.

19.

Comprehensive analysis of mycolic acid subclass and molecular species composition of Mycobacterium bovis BCG Tokyo 172 cell wall skeleton (SMP-105).

Uenishi Y, Fujita Y, Kusunose N, Yano I, Sunagawa M.

J Microbiol Methods. 2008 Feb;72(2):149-56. doi: 10.1016/j.mimet.2007.11.016.

PMID:
18178279
20.

Supplemental Content

Support Center